The dual PDE3/PDE4 phosphodiesterase inhibitor RPL554 produces more complete bronchodilator responses than the beta2-agonist salbutamol and the anti-muscarinic agent ipratropium bromide, alone and in combination, in guinea-pig isolated trachea
EUROPEAN RESPIRATORY JOURNAL(2015)
摘要
Introduction: RPL554 causes clinically effective bronchodilation in asthma and COPD (Franciosi, L.G et al. Lancet Respir Med 2013; 1:714-727) by relaxation of human airway smooth muscle (Calzetta, L et al. J Pharmacol Exp Ther 2013; 346:414-423). Aims: To investigate whether RPL554 provides additional functional antagonism to relaxant agonists against bronchomotor tone induced by different spasmogens. Methods: Bronchomotor tone in guinea-pig isolated trachea was elicited by carbachol/histamine (10 µM each) in the absence or presence of LTC4 (100 nM) or K + ions (40 mM) and carbachol (10 µM) followed by relaxation to ipratropium bromide (IB), salbutamol (SALB) alone, in combination (1:5.7, respectively, and referred to as Combivent); glycopyrrolate (GLY); and RPL554. Maximal relaxation (% Emax papaverine) expressed as mean±sem (N=3-6 animals). Results: In tissues contracted with carbachol/histamine, only IB failed to fully reverse bronchomotor tone (75±5 %). In tissues contracted with LTC4/histamine/carbachol the response to these agents differed (IB, 69±9; SALB, 72±6; 9combivent9, 95±3, GLY, 62±4, and RPL554, 97±1). Tissues contracted with potassium ions u0026 carbachol were more resistant to these agents (IB, 73±6; SALB, 48±8; Combivent, 82±4, RPL554, 90±5). RPL554 provided additional relaxation when bronchodilator drugs did not achieve maximum relaxation in this preparation. Conclusion . RPL554 has the clinical potential to produce additional bronchodilation over and above that of standard bronchodilators in highly constricted airways.
更多查看译文
关键词
Pharmacology,Airway smooth muscle,Bronchodilators
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要